News

Bronchial thermoplasty gains momentum for severe asthma

Publish date: April 13, 2015

 

EXPERT ANALYSIS FROM THE 2015 AAAAI ANNUAL MEETING

References

An estimated 5% of asthma patients are categorized as having severe disease. Bronchial thermoplasty has been approved by the FDA for the treatment of severe asthma since 2010. The outpatient procedure entails delivery of radiofrequency energy to the lungs in three sessions spaced several weeks apart.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

COPD patients more likely to be unemployed, less physically active
MDedge Internal Medicine
Identifying as a nonsmoker may help ex-smokers stay abstinent
MDedge Internal Medicine
Executive function deficits linked to e-cigarette use in early adolescents
MDedge Internal Medicine
Sitting while watching television tied to poor sleep, obstructive sleep apnea risk
MDedge Internal Medicine
U.S. grants drug company $12 million to develop Ebola drug
MDedge Internal Medicine
Beta-lactam monotherapy effective for suspected community-acquired pneumonia
MDedge Internal Medicine
No increased risk of lung disease with methotrexate
MDedge Internal Medicine
Avoid voriconazole in transplant patients at risk for skin cancer
MDedge Internal Medicine
Early pneumonia linked with later asthma and COPD
MDedge Internal Medicine
‘Mossy Oak sign’ suggests delayed anaphylaxis to red meat
MDedge Internal Medicine